MICROBOT MEDICAL INC.: 10-Q filed 2015-11-02

Name: MICROBOT MEDICAL INC.: 10-Q filed 2015-11-02
Creator: MICROBOT MEDICAL INC.

What MICROBOT MEDICAL INC. reported in its quarterly report filed 2015-11-02 (fiscal Q3 2015): 37 published measures, 95 facts as tagged in accession 0001193125-15-362412.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-02
Fiscal period: fiscal Q3 2015
Accession: 0001193125-15-362412 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MICROBOT MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	28,382,055	USD
At 2014-12-31	32,426,759	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	21,273,087	USD
At 2014-12-31	26,555,986	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	7,108,968	USD
At 2014-12-31	5,870,773	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	21,185,263	USD
At 2014-12-31	24,987,603	USD
At 2014-09-30	32,212,589	USD
At 2013-12-31	30,585,424	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-9,642,647	USD	92
2015-01-01 to 2015-09-30	-27,455,062	USD	273
2014-07-01 to 2014-09-30	-2,757,186	USD	92
2014-01-01 to 2014-09-30	-22,492,666	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-23,750,255	USD	273
2014-01-01 to 2014-09-30	-20,960,576	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	1,005,273	USD	273
2014-01-01 to 2014-09-30	598,432	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	37,030	USD	92
2015-01-01 to 2015-09-30	88,158	USD	273
2014-07-01 to 2014-09-30	82,406	USD	92
2014-01-01 to 2014-09-30	129,469	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	20,802,444	USD	273
2014-01-01 to 2014-09-30	23,191,816	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-836,560	USD	273
2014-01-01 to 2014-09-30	-598,432	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-447,726,670	USD
At 2014-12-31	-420,271,608	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	5,441,329	USD
At 2014-12-31	5,186,958	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	4,086,710	USD	273
2014-01-01 to 2014-09-30	1,543,577	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-9,987,931	USD	92
2015-01-01 to 2015-09-30	-28,220,904	USD	273
2014-07-01 to 2014-09-30	-6,379,584	USD	92
2014-01-01 to 2014-09-30	-21,181,192	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	22,272,680	USD
At 2014-12-31	26,507,971	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	106,843	USD	92
2015-01-01 to 2015-09-30	438,466	USD	273
2014-07-01 to 2014-09-30	311,349	USD	92
2014-01-01 to 2014-09-30	1,035,061	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	9,635,379	USD
At 2014-12-31	11,497,871	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	1,391,716	USD
At 2014-12-31	1,818,831	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	2,625	USD
At 2014-12-31	159,466	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	10,024,961	USD	92
2015-01-01 to 2015-09-30	28,309,062	USD	273
2014-07-01 to 2014-09-30	6,461,990	USD	92
2014-01-01 to 2014-09-30	21,310,660	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	7,719,720	USD	92
2015-01-01 to 2015-09-30	21,250,896	USD	273
2014-07-01 to 2014-09-30	4,396,873	USD	92
2014-01-01 to 2014-09-30	14,865,874	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	108,589,273	shares
At 2014-12-31	68,729,774	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-09-30	46,873	USD
At 2014-12-31	65,390	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-09-30	12,424,560	USD
At 2014-12-31	15,595,756	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-09-30	6,983,231	USD
At 2014-12-31	10,408,798	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-09-30	294,329	USD
At 2014-12-31	356,889	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	373,717	USD
At 2014-12-31	373,717	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	399,370	USD
At 2014-12-31	1,250,007	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	5,627,486	USD
At 2014-12-31	4,869,710	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	2,305,241	USD	92
2015-01-01 to 2015-09-30	7,058,166	USD	273
2014-07-01 to 2014-09-30	2,065,117	USD	92
2014-01-01 to 2014-09-30	6,444,786	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	274,000	USD	92
2015-01-01 to 2015-09-30	778,000	USD	273
2014-07-01 to 2014-09-30	246,000	USD	92
2014-01-01 to 2014-09-30	766,000	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	840,533	USD	273
2014-01-01 to 2014-09-30	992,612	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	21,000	USD	92

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	22,367	USD	92
2015-01-01 to 2015-09-30	129,978	USD	273
2014-07-01 to 2014-09-30	-7,244	USD	92
2014-01-01 to 2014-09-30	-38,128	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	345,284	USD	92
2015-01-01 to 2015-09-30	765,842	USD	273
2014-07-01 to 2014-09-30	3,759,990	USD	92
2014-01-01 to 2014-09-30	-971,826	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	24,942,963	USD	273
2014-01-01 to 2014-09-30	18,952,721	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-152,877	USD	273
2014-01-01 to 2014-09-30	-37,121	USD	273

Inspect the source

Entity: MICROBOT MEDICAL INC. / CIK 0000883975
Captured: 2026-09-20T05:02:19.185Z
SEC response SHA-256: 5fc792c757c83821aa0cd636b3655419924829213ef914d8be1d9f56dce19054

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000883975.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))